Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $10.99, but opened at $10.60. Veradigm shares last traded at $10.60, with a volume of 50,166 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com started coverage on shares of Veradigm in a report on Sunday, November 17th. They set a "hold" rating on the stock. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $11.75.
View Our Latest Report on MDRX
Veradigm Price Performance
The stock has a 50-day moving average of $9.69 and a 200-day moving average of $9.41.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new stake in shares of Veradigm Inc. (NASDAQ:MDRX - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,974 shares of the software maker's stock, valued at approximately $38,000.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
